The continuing challenge of retroperitoneal sarcomas

Area of Science:

• Oncology
• Surgical Oncology
• Medical Physics

Background:

• Retroperitoneal sarcomas are rare malignancies requiring complex management.
• Historical treatment outcomes for these tumors present significant challenges.

Purpose of the Study:

• To evaluate the long-term survival and recurrence rates of retroperitoneal sarcomas treated with surgical excision.
• To identify prognostic factors influencing patient survival and disease control.
• To assess the potential role of adjuvant therapies in improving outcomes.

Main Methods:

• Retrospective analysis of 158 patients with retroperitoneal sarcomas treated between 1951 and 1977.
• Evaluation of survival rates based on surgical completeness (complete vs. incomplete excision).
• Analysis of factors including histology, tumor grade, and recurrence patterns.

Main Results:

• Mean five-year survival was 40% after complete excision, with only 22% disease-free.
• Survival dropped to 3% after incomplete excision.
• Operative mortality for complete excision decreased from 21% to 2% over the study period.
• High-grade histology, anatomical barriers, and local recurrence were key negative prognostic factors.
• A 77% recurrence rate was observed even after apparent complete excision.

Conclusions:

• Complete surgical excision is critical for improving survival in retroperitoneal sarcoma patients.
• Adjuvant therapies, including brachytherapy (125Iodine, 192Iridium) and external radiation, are recommended for local control.
• Chemotherapy should be considered to reduce metastatic spread.
• Further research is needed to definitively assess adjuvant therapy's contribution due to confounding variables.